
Xitiz Pharma Private Limited
Founded in 1998 and headquartered in West Bengal, India.
Founded in 1998 and headquartered in West Bengal, India.
South 24 Parganas, West Bengal, India
+91-XXXXXXXXXX
U85195WB1998PTC088190
088190
Private Limited Indian Non-Government Company
03 Nov 1998
30 Nov 2021
31 Mar 2021
Unlisted
Roc Kolkata
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rohit Nahar ![]() | Director | 03-Nov-1998 | Current |
Rekha Nahar ![]() | Director | 03-Nov-1998 | Current |
Xitiz Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Xitiz Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Rohit Nahar is a mutual person
Rohit Nahar is a mutual person
Rohit Nahar is a mutual person
Rohit Nahar is a mutual person
Rohit Nahar and Rekha Nahar are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Xitiz Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xitiz Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xitiz Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Xitiz Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Xitiz Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Kolkata.
Rekha Nahar was appointed as a Director was appointed as a Director on 03 Nov 1998 & has been associated with this company since 26 years 6 months .
Rohit Nahar was appointed as a Director was appointed as a Director on 03 Nov 1998 & has been associated with this company since 26 years 6 months .
Xitiz Pharma Private Limited was registered on 03 Nov 1998 with Roc Kolkata & aged 26 years 6 months as per MCA records.
Xitiz Pharma Private Limited was incorporated on 03 Nov 1998.
The authorized share capital of Xitiz Pharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.38 M.
Currently 2 directors are associated with Xitiz Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Xitiz Pharma Private Limited is K.P. Mondal Road Nodakhali, P.O- Bowali Chandipur, Kolkata, West Bengal, India, 700137.
The corporate identification number (CIN) of Xitiz Pharma Private Limited is U85195WB1998PTC088190 and the company number is 088190 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Xitiz Pharma Private Limited was filed with the ROC on 31 Mar 2021.
Search company & director profiles for free and gain access to critical business data.